Skip to search.
 All Ordinaries Up 0.61%

Synta Pharmaceuticals Corp. (SNTA)

-NasdaqGM
2.06 Up 0.08(4.04%) 29 Aug 06:00
Add to Portfolio
Prev Close:1.98
Open:1.95
Bid:2.06 x 100
Ask:2.50 x 1900
1y Target Est:10.13
Beta:2.54626
Earnings Date:4 Nov - 9 Nov (Est.)
Day's Range:1.92 - 2.06
52wk Range:1.75 - 4.05
Volume:776,055
Avg Vol (3m):1,196,650
Market Cap:281.07M
P/E (ttm):N/A
EPS (ttm):-0.71
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
SNTAUp 4.04%281.07M
INFIUp 1.75%456.47M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.65
Quarterly EPS Est (Sep-15) :-0.16
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Synta Pharmaceuticals Corp., a biopharmaceutical company, focuses on the research, development, and commercialization of novel oncology medicines for cancer patients. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback